Rho family of GTPases
The Rho family of GTPases is a family of small (~21 kDa) signaling G protein (more specific, a GTPase), and is a subfamily of the Ras superfamily. The members of the Rho GTPase family have been shown to regulate many aspects of intracellular actin dynamics, and are found in all eukaryotic organisms as well as in yeasts and some plants. Three members of the family have been particularly much-studied: Cdc42, Rac1, and RhoA. The members have been described as ‘molecular switches’ and have been described as playing a role in cell proliferation, apoptosis, cell division, gene expression, and multiple other common cellular functions.
Identification of the Rho family of GTPases began in the late 1980s. The first report of the cloning and expression of Cdc42 was in 1990 with the Munemitsu et al. paper entitled, “Molecular Cloning and Expression of a G25K cDNA, the human homolog of the yeast cell cycle gene CDC42”. Since the early 1990s, numerous Rho GTPases have been identified, and today 22 Rho GTPases have been identified in mammals.
As early as 1990, Paterson et al. began injecting active rho protein into Swiss 3T3 cells..
In the 2006 review article released by Bement et al., the spatial zones of rho activation were explained.
As early as the mid-1990s, these processes and the effects of the rho proteins were observed in fibroblasts. Dr. Alan Hall, one of the front-runners in rho protein research, compiled evidence in his 1998 review, which showed that it is not only fibroblasts that formed processes based on rho activation, but virtually all eukaryotic cells.
The Rho family of GTPases belong to the superfamily named ‘Ras-like’ proteins, which consists of over 150 varieties in mammals. Rho proteins sometimes denote some members of the Rho family (RhoA, RhoB, and RhoC), and sometimes refers to all members of the family. This article is about the family as a whole.
In mammals, the Rho family contains 22 members. Almost all research involves the three most common members of the Rho family: Cdc42, Rac1 and RhoA.
|Rho family member||Action on actin filaments|
|RhoA||affects stress fibres|
The current 22 members of the Rho family include RhoA, RhoB, RhoC, RhoD, Rif, Rnd1, Rnd2, Rnd3/RhoE, RhoH/TTF, Rac1, Rac2, Rac3, RhoG, Cdc42, TC10 (RhoQ), TCL (RhoJ), Wrch1 (RhoV), Chp/Wrch2 (RhoU), RhoBTB1, RhoBTB2, Miro1 (RhoT1), Miro2 (RhoT2).
|Subclass||Cytoskeletal effect||Rho family members|
|Rho (subclass)||↑stress fibres and ↑focal adhesions||RhoA|
|Rnd||↓stress fibres and ↓focal adhesions||Rnd1|
|RhoD||Vesicle transport, filopodia||RhoD|
Three general classes of regulators of rho protein signaling have been identified: guanine nucleotide exchange factor (GEFs), GTPase-activating proteins (GAPs) and guanine nucleotide dissociation inhibitors (GDIs). GEFs control the release of GDP from the rho protein and the replacement with GTP. GAPs control the ability of the GTPase to hydrolyze GTP to GDP, controling the natural rate of movement from the active conformation to the inactive conformation. GDI proteins form a large complex with the rho protein helping to prevent diffusion within the membrane and into the cytosol, thus acting as an anchor and allowing for very specific spatial control of rho activation.
Important GEFs for Rho GTPase include many G-protein-coupled receptors:
- Prostaglandin F2α receptor. Rho-activation may be involved in Prostaglandin F2α-mediated contraction of gastrointestinal tract sphincters. 
Each Rho protein affects numerous proteins downstream, all of which have roles in various cell processes. In fact, over 60 targets of the three common Rho GTPases have been found. Two molecules that directly stimulate actin polymerization are the WASP/WAVE proteins and the Diaphanous-related formins.
|RhoA||Cit, Cnksr1, Diaph1, Diaph2, DgkQ, FlnA, KcnA2, Ktn1, Rtkn1, Rtkn2, Rhpn1, Rhpn2, Itpr1, PlcG1, PI-5-p5K, Pld1, Pkn1, Pkn2, Rock1, Rock2, PrkcA, Ppp1r12A|
|Rac1||Sra1, IRSp53, PAK1, PAK2, PAK3|
|Cdc42||Wiskott-Aldrich syndrome protein, N-WASP, IRSp53, Dia2, Dia3, ROCK1, ROCK2|
Rho/Rac proteins are involved in a wide variety of cellular functions such as cell polarity, vesicular trafficking, the cell cycle and transcriptomal dynamics .
Animal cells form many different shapes based on their function and location in the body. Rho proteins help cells regulate changes in shape throughout their life-cycle. Before cells can undergo key processes such as budding, mitosis, or locomotion, a certain degree of polarity is required. A ‘polar’ cell is one that has some sort of shape or direction rather than existing as an amorphous, symmetrical shape. For instance, an amoeba becomes polar when it undergoes locomotion and travels from one point to another.
One example of Rho GTPases' role in cell polarity is seen in the much-studied yeast cell. Before the cell can bud, Cdc42 is used to locate the region of the cell’s membrane which will begin to bulge into the new cell. When Cdc42 is removed from the cell, the cell’s outgrowths still form but form in an unorganized manner.
One of the most obvious changes to cell morphology controlled by rho proteins is the formation of lamellipodia and filopodia, the processes that look like fingers or feet, which often propel cells across surfaces. Fibroblasts form processes based on rho activation, but also virtually all eukaryotic cells do so as well.
Much of what is known about cellular morphology changes, and the effects of Rho proteins comes from the creation of a constituently-active mutation of the protein, e.g., by injecting active rho protein into Swiss 3T3 cells. The proteins is made to be constituently active using recombinant techniques. In essence, by changing one codon of the protein’s DNA, one amino acid is changed, and, therefore, the conformation of the entire protein is altered into one that resembles the GTP-bound state. After injection into the 3T3 cells, morphological changes ensue - contractions and filopodia .
Because rho proteins are ‘G proteins’ and plasma-membrane-bound, their location can be easily controlled. In each situation, whether it be wound-healing, cytokinesis, or budding, the location of the rho activation can be imaged and identified. For example, if a circular hole is inflicted in a spherical cell, Cdc42 and other active rhos are seen in highest concentration around the circumference of the circular injury. One methods of maintaining the spatial zones of activation is, e.g., through anchoring to the actin cytoskeleton, keeping the membrane-bound protein from diffusing away from the region where it is most needed. Another method of maintenance is through the formation of a large complex which is resistant to diffusion and more rigidly bound to the membrane than the rho itself .
In addition to the formation of lamellipodia and filopodia, it has been shown that intracellular concentration and cross-talk between different rho proteins drives the extensions and contractions that cause cellular locomotion. Sakumura et al. proposed a model based on differential equations, which helps explain the activity of rhos and their relationship to motion. This model encompassed the three proteins Cdc42, RhoA, and Rac. Cdc42 was assumed to encourage filopodia elongation and block actin depolymerization. RhoA was considered to encourage actin retraction. Rac was treated to encourage lamellipodia exentsion but block actin depolymerization. These three proteins, although significantly simplified, covered the key steps in cellular locomotion. Through various mathematical techniques, solutions to the differential equations that described various regions of activity based on intracellular activity were found. The paper concludes by showing that the model predicts that there are a few threshold concentrations that cause interesting effects on the activity of the cell. Below a certain concentration, there is very little activity, causing no extension of the arms and feet of the cell. Above a certain concentration, the rho protein causes a sinusoidal oscillation to occur, much like the extensions and contractions of the lamellipodia and filopodia. In essence, this model predicts that increasing the intracellular concentration of these three key active rho proteins causes an out-of-phase activity of the cell, resulting in extensions and contractions that are also out of phase.
One example of behavior that is modulated by Rho GTPase proteins is in the healing of wounds. Wounds heal differently between young chicks and adult chickens. In young chicks, wounds heal by contraction, much like a draw-string being pulled to close a bag. In older chickens, cells crawl across the wound through locomotion. The actin formation required to close the wounds in young chicks is controlled by Rho GTPase proteins, since, after injection of a bacterial exoenzyme used to block rho and rac activity, the actin polymers do not form, and thus the healing completely fails.
Another cellular behavior that is affected by rho proteins is phagocytosis. As with most other types of cell membrane modulation, phagocytosis requires the actin cytoskeleton in order to engulf other items. The actin filaments control the formation of the phagocytic cup, and active Rac1 and Cdc42 have been implicated in this signaling cascade.
Yet another major aspect of cellular behavior that is thought to include rho protein signaling is the process of cell division, mitosis. While it was thought for years that rho GTPase activity is restricted only to actin polymerization and therefore only to cytokinesis, new evidence that shows some activity in microtubule formation and the overall process of mitosis has arisen. This topic is still debated, and there is evidence both for and against for the importance of rho in mitosis.
Nervous System Regeneration
Because of their implications in cellular motility and shape, rho proteins became a clear target in the study of the growth cones that form during axonal generation and re-generation in the nervous system. Some consider rho proteins to be a potential target for delivery into spinal cord lesions after traumatic injury. Following injury to the spinal cord, the extracellular space becomes inhibitory to the natural efforts neurons undergo to regenerate.
These ‘natural efforts’ include the formation of a growth cone at the proximal end of an injured axon. Newly-formed growth cones subsequently attempt to ‘crawl’ across the lesion and are quite sensitive to chemical cues in the extracellular environment. One of the many inhibitory cues includes chondroitin sulfate proteoglycans or CSPGs. Neurons growing in culture increase in their ability to cross over inhibitory CSPG lanes after administration of constituently-active Cdc42, Rac1 and RhoA. This is partly due to the exogenous rho proteins driving cellular locomotion despite the extracellular cues promoting apoptosis and growth cone collapse. It is situations like these that make intracellular modulation of rho proteins the subject of a significant amount of spinal cord research.
Rho proteins have also been implicated in mental retardation. Mental retardation occurs in approximately 3% of the population and is characterized by having an IQ of less than 70. Multiple sources have noticed that mental retardation in some cases shows malformation of the dendritic spines, which form the post-synaptic connections between neurons. As expected, the misshapen dendritic spines are sometimes the result of rho protein-signaling modulation. After cloning of various genes implicated in X-linked mental retardation, three genes that have effects on rho signaling were identified, including oligophrenin-1 (GAP protein that stimulates GTPase activity of Rac1, Cdc42, and RhoA), PAK3 (involved with the effects of Rac and Cdc42 on the actin cytoskeleton) and αPIX (a GEF that helps activate Rac1 and Cdc42). Because of the effect of rho signaling on the actin cytoskeleton, genetic malfunctions of a rho protein could explain the irregular morphology of neuronal dendrites seen in many cases of mental retardation.
After finding that Ras proteins are mutated in 30% of human cancers, it was suspected that mutated rho proteins are also involved in cancer reproduction, as the signaling pathways involving rho proteins are widely known to play an important role in cancer development. However, Ellenbroek et al. reported in their review that, as of August 2007, no mutations have been found in rho proteins, and only one has been found to be genetically altered. To explain the role of rho pathways without mutation, researchers have now turned to the regulators of rho activity and the levels of expression of the rho proteins for answers.
One way to explain altered signaling in the absence of mutation is through increased expression. Overexpression of RhoA, RhoB, RhoC, Rac1, Rac2, Rac3, RhoE, RhoG, RhoH, and Cdc42 has been shown in multiple types of cancer. This increased presence of so many signaling molecules implies that these proteins promote the cellular functions that become overly active in cancerous cells.
A second target to explain the role of the rho proteins in cancer is their regulatory proteins. Rho proteins are very tightly controlled by a wide variety of sources, and over 60 activators and 70 inactivators have been identified. Multiple GAPs, GDIs, and GEFs have been shown to undergo overexpression, downregulation, or mutation in different types of cancer. As one can imagine, once an upstream signal is changed, the activity of its targets downstream, i.e. the rho proteins, will change in activity.
Ellenbroek et al. outlined a number of different effects of rho activation in cancerous cells. First, in the initiation of the tumor modification of rho activity can suppress apoptosis and therefore contribute to artificial cell longevity. After natural apoptosis is suppressed, abnormal tumor growth can be observed through the loss of polarity in which rho proteins play an integral role. Next, the growing mass can invade across its normal boundaries through the alteration of adhesion proteins potentially caused by rho proteins. Finally, after inhibition of apoptosis, cell polarity and adhesion molecules, the cancerous mass is free to metastasize and spread to other regions of the body.
- Boureux A, Vignal E, Faure S, Fort P. (2007). "Evolution of the Rho family of ras-like GTPases in eukaryotes". Mol Biol Evol. 24 (1): 203–16. doi:10.1093/molbev/msl145. ISSN 0737-4038. PMID 17035353.
- Bustelo XR, Sauzeau V, Berenjeno IM. (2007). "GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo". Bioessays. 29 (4): 356–370. doi:10.1002/bies.20558. PMID 17373658.
- Munemitsu S, Innis M, Clark R, McCormick F, Ullrich A, Polakis P. (1990). "Molecular cloning and experssion of a G25K cDNA, the human homolog of the yeast cell cycle gene CDC42". Mol Cell Biol. 10 (11): 5977–82. ISSN 0270-7306. PMID 2122236.
- Ridley A. (2006). "Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking". Trends Cell Biol. 16 (10): 522–9. doi:10.1016/j.tcb.2006.08.006. ISSN 0962-8924. PMID 16949823.
- Paterson HF, Self AJ, Garrett MD, Just I, Aktories K, Hall A. (1990). "Microinjection of recombinant p21 rho induces rapid changes in cell morphology". J Cell Biol. 111 (3): 1001–7. doi:10.1083/jcb.111.3.1001. ISSN 0021-9525. PMID 2118140.
- Hall A. (1998). "Rho GTPases and the actin cytoskeleton". Science. 279 (5350): 509–14. doi:10.1126/science.279.5350.509. ISSN 0036-8075. PMID 9438836.
- Ellenbroek S, Collard J. (2007). "RhoGTPases: functions and association with cancer". Clin Exp Metastasis. 24 (8): 657–72. doi:10.1007/s10585-007-9119-1. ISSN 0262-0898. PMID 18000759.
- Signal transduction in lower esophageal sphincter circular muscle Piero Biancani, Ph.D. and Karen M. Harnett, Ph.D
- Etienne-Manneville S, Hall A. (2002). "Rho GTPases in cell biology". Nature. 420 (6916): 629–35. doi:10.1038/nature01148. ISSN 0028-0836. PMID 12478284.
- Bement WM, Miller AL, von Dassow G. (2006). "Rho GTPase activity zones and transient contractile arrays". Bioessays. 28 (10): 983–93. doi:10.1002/bies.20477. ISSN 0265-9247. PMID 16998826.
- Sakumura Y, Tsukada Y, Yamamoto N, Ishii S. (2005). "A molecular model for axon guidance based on cross talk between rho GTPases". Biophys J. 89 (2): 812–22. doi:10.1529/biophysj.104.055624. ISSN 0006-3495. PMID 15923236.
- Brock J, Midwinter K, Lewis J, Martin P. (1996). "Healing of incisional wound in the embryonic chick wing bud: characterization of the actin purse-string and demonstration of a requirement for Rho activation". J Cell Biol. 135 (4): 1097–107. doi:10.1083/jcb.135.4.1097. ISSN 0021-9525. PMID 8922389.
- Niedergang F, Chavrier P. (2005). "Regulation of phagocytosis by Rho GTPases". Curr Top Microbiol Immunol. 291: 43–60. ISSN 0070-217X. PMID 15981459.
- Narumiya S, Yasuda S. (2006). "Rho GTPases in animal cell mitosis". Curr Opin Cell Biol. 18 (2): 199–205. doi:10.1016/j.ceb.2006.02.002. ISSN 0955-0674. PMID 16487696.
- Jain A, Brady-Kalnay SM, Bellamkonda RV. (2004). "Modulation of Rho GTPase activity alleviates chondroitin sulfate proteoglycan-dependent inhibition of neurite extension". J Neurosci Res. 77 (2): 299–307. doi:10.1002/jnr.20161. ISSN 0360-4012. PMID 15211597.
- Ramakers GJ. (2002). "Rho proteins, mental retardation and the cellular basis of cognition". Trends Neurosci. 25 (4): 191–9. doi:10.1016/S0166-2236(00)02118-4. ISSN 0166-2236. PMID 11998687.